Sign up to save your podcasts
Or
Share How A Wall Street Analyst Started A $4 Billion Obesity Drug Company
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How A Wall Street Analyst Started A $4 Billion Obesity Drug Company
Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling for their share of a potential $100 billion market.
View all episodes
By Forbes
4.3
1616 ratings
Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling for their share of a potential $100 billion market.
More shows like Forbes Daily Briefing
View all
Economist Podcasts
4,225 Listeners
Motley Fool Money
3,228 Listeners
WSJ Your Money Briefing
1,713 Listeners
WSJ What’s News
4,420 Listeners
World Business Report
296 Listeners
Odd Lots
1,993 Listeners
WSJ Tech News Briefing
1,649 Listeners
HBR IdeaCast
154 Listeners
WSJ Minute Briefing
686 Listeners
Wall Street Breakfast
1,044 Listeners
Steve Forbes: What's Ahead
505 Listeners
The Journal.
6,097 Listeners
The World in Brief from The Economist
1,089 Listeners
Reuters World News
302 Listeners
Bloomberg Daybreak: US Edition
87 Listeners
Forbes Talks
6 Listeners
Forbes Newsroom
5 Listeners